![](/img/cover-not-exists.png)
Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acid
Christopher W. Ryan, Dezheng Huo, Kathryn Bylow, Laurence M. Demers, Walter M. Stadler, Tara O. Henderson, Nicholas J. VogelzangVolume:
100
Year:
2007
Language:
english
Pages:
6
DOI:
10.1111/j.1464-410x.2007.06853.x
File:
PDF, 174 KB
english, 2007